Michael Gardner’s newest job arrived after the résumé most people would consider complete. By 2019, he had already built a career across chemistry, biomechanics, research, teaching, surgery, and hospital operations. He was a professor at Stanford, the chief of an orthopaedic service, and a vice chair responsible for clinical operations. He had published at a pace that makes the word “prolific” feel strangely imprecise. Then he began working on an AI-based scanning application, the early technical core of the company now called MyBackHub.
The order is the interesting part. Gardner did not begin with a software thesis and go looking for a domain. He began with a domain that had occupied his adult life and slowly noticed the boundaries of the institutions around him. Specialist judgment was valuable, but it was attached to a person, a room, and a calendar. The founder question was whether some of that judgment could be organized into a system that moved more freely.
His public biography can look like two careers stapled together. There is Michael Gardner, the academic surgeon with an endowed chair at Stanford. Then there is Mike Gardner, the co-founder and CEO who stands on an industry stage talking about algorithms, monthly recurring revenue, acquisition costs, payer pathways, and daily customer conversations. Look closer and the seam disappears. Both careers are about how decisions become repeatable.
Before the company, a sequence of systems
Gardner grew up in Massachusetts and studied chemistry at Williams College, graduating magna cum laude in 1996. Chemistry offered a language of structure and interaction. Medical school in Philadelphia followed, then an internship at Cornell’s medical center in New York. At Hospital for Special Surgery, he completed an orthopaedic residency and stepped sideways for a year into the biomechanics laboratory. The detour matters. Biomechanics turns physical intuition into variables that can be examined, challenged, and measured.
A fellowship at Harborview Medical Center in Seattle sharpened the specialist side of his work. Then came seven years at Washington University in St. Louis, where Gardner eventually directed the orthopaedic trauma research program. Stanford recruited him in 2016. He arrived not only as a professor but also as chief of the Orthopaedic Trauma Service and vice chair of clinical operations. The titles joined scholarship to the less romantic work of making a large organization function.
Operations is where elegant ideas meet pagers, staffing, budgets, handoffs, and Monday morning. It trains a person to see the difference between something that works once and something that works reliably. Gardner’s research record suggests the same instinct from another angle: formulate the question, make the method visible, gather evidence, and let other people test the result.
Stanford credits him with more than 180 scientific articles, 38 book chapters, five edited textbooks, and the training of more than 100 surgeons. These figures describe more than output. A paper makes a claim portable. A textbook makes a technique teachable. Training another professional forces tacit judgment into words, demonstrations, and feedback. Long before Gardner built a digital product, he was already working on the transfer problem.
His service beyond Stanford follows the same pattern. Gardner has reviewed grants for the Department of Defense, served on the editorial board of the Journal of Orthopaedic Trauma, and worked on research, publications, and annual-meeting committees for the Orthopaedic Trauma Association. Committee work rarely becomes the bright line in a biography. It is still where a field decides which questions deserve attention, how results should be evaluated, and which practices become shared standards. The experience puts Gardner on both sides of scrutiny: producing work for review and helping review the work of others.
“We talk to our customers every day to improve the user experience.”Michael Gardner, LSI USA ’24
A narrow door into a wider room
The company began with a focused identity: National Scoliosis Clinic. Gardner says development of its AI-based scanning application started in 2019. The initial idea paired mobile computer vision with a virtual program and a membership model. In 2023, according to the company, the application received its first FDA clearance. A direct-to-consumer launch followed, giving the team something academic work does not always provide quickly: daily contact with people choosing whether a product earned another minute of attention.
At LSI USA in 2024, Gardner sounded less like someone delivering a grand theory than an operator narrating a sequence. The team was talking to customers, improving the algorithm, adjusting the product, collecting real-world evidence, and opening partnership conversations. He moved between user experience and economics without ceremony. That is how a business actually appears from the inside: not a single breakthrough, but several uncertain loops running at once.
In 2025, the company changed its name to MyBackHub and widened its scope. Rebrands often produce fog. This one clarified the strategic move: the original category had become the entrance to a broader navigation platform. The organization was no longer presenting itself as a clinic translated onto a screen. It was describing an ecosystem of assessment, guidance, experts, community, and ongoing support, offered to individuals as well as organizations.
Gardner’s two roles give the expansion a productive tension. Academia rewards caution, attribution, peer review, and the slow accumulation of confidence. Startups reward speed, focus, sales, and learning before money disappears. A founder formed entirely in one culture can caricature the other. Gardner has to live inside both at the same time.
What happens when expertise can travel?
The latest chapter puts that tension in a new setting. MyBackHub joined the February 2026 Mayo Clinic Platform_Accelerate cohort, a program that brings technology companies together with Mayo Clinic experts and de-identified, structured data. By June, Mayo Clinic Platform listed the cohort at its halfway point. Gardner separately described the collaboration as a way to improve the company’s AI models and decision pathways.
The partnership is a logical next test. A product built from specialist pattern recognition eventually needs to prove that it can perform beyond the intuition of its builders. It needs larger data, external expertise, better validation, and a clear account of where the software should defer. Gardner’s academic life has been preparing him for that demand. His startup life is forcing the answer into a form that people can actually use.
There is also a management lesson hidden in the numbers. More than 100 trained surgeons means Gardner’s influence has already traveled through people. Five textbooks mean it has traveled through pages. MyBackHub asks whether it can travel through software. Each medium compresses expertise differently. People carry nuance but are difficult to scale. Books scale but cannot respond. Software responds, but only within the boundaries its makers have designed and tested.
This makes the founder story more grounded than the familiar tale of disruption. Gardner is not entering an unknown field with a claim that incumbents understand nothing. He is an incumbent in the literal sense: a department leader, journal editor, grant reviewer, teacher, and researcher. He knows why institutions move carefully because he helps operate one. His bet is that care and judgment can become more accessible without pretending the hard parts have vanished.
His own language stays close to sequence. In public presentations and posts, he returns to timing, setting, data, evidence, and who should make which decision. Even the customer quote is procedural: talk every day, improve the experience. It is an ordinary sentence carrying a large cultural shift. The professor is not waiting for a finished answer before entering the room. The CEO is not treating iteration as permission to forget proof.
Gardner’s career is still accumulating. MyBackHub remains a young company beside the institutions that formed him. Its rebrand is recent. Its Mayo Clinic Platform work is underway. The public evidence supports a direction, not a verdict. That is what makes this moment worth watching. He has spent decades learning to make expert work reproducible. Now he is testing whether the same instinct can build an organization, a product, and a new channel for judgment.
A second operating system does not replace the first. It sits beside it, borrowing discipline from the old environment while accepting the pressure of the new one. Gardner’s project is to make those two clocks tick together. The company will be judged by what the system does. The career behind it explains why he chose to build one at all.